Strategic, results-oriented Sales Representative with 10+years’ experience in clinical sales, promoting major brands, demonstrated acumen in the development and execution of Call Plans for multiple territories.
Diabetes Sales Specialist on BI Contract - Jardiance, Glyxambi, Tradjenta, Jentadueto and Synjardy
Call Points: Primary Care
Key Accomplishments:
Q2 2017: July TRx increased 24.30%(Rolling 13 Week)
Q2 2017: July NRx increased 33.80%(Rolling 13 Week)
Q3 2017: Aug TRx increased growth 96%(Rolling 13 Week)
Q3 2017: Aug NRx increased growth 58.30% (Rolling 13 Week)
Collaborated with colleagues from AstraZeneca/Daichii Sankyo to maximize productivity in assigned territory.
Call Points: Primary Care physicians, Gastroenterologists, Orthopedic Surgeons and Pain Specialists
Diabetes Sales Specialist 3/2014 – 8/2015
Launched/promoted Farxiga-SGLT2 Inhibitor/Xigduo XR-SGLT2i+ Metformin
Call Points: Primary Care Physicians, NPs, PAs, and Endocrinologists treating adult patients with Type 2 Diabetes currently not at goal with their current regimen.
Key Accomplishments:
Q2 2014: Increased Onglyza Sales 122% to Goal
Q3 2014: Increased Onglyza Sales 124% to Goal
Q4 2014: Increased Farxiga Sales 104% to Goal
Q1 2015: Awarded Merit Increase Based On Performance
Q1 2015: SIP $1500 Contest Winner +3.6% Farxiga TRx Market Share Change